Squarepoint’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYME
Squarepoint's ZYME Position: Q3 2026 in Review
Squarepoint increased its Zymeworks (ZYME) stake by 273% in Q3 2026, buying an estimated $1.15M and bringing the position to 60,496 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2376.
Squarepoint first reported a position in ZYME in Q2 2018 and has held it in 19 quarters since. The position peaked at $3.76M in Q3 2025. 203 funds tracked by Wall St. Rank hold ZYME as of Q3 2026.
- Squarepoint held 60,496 shares of Zymeworks worth $1.6M as of Q3 2026.
- Squarepoint bought 44,296 Zymeworks shares in Q3 2026, an estimated $1.15M.
- Zymeworks made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #2376 holding.
- Squarepoint first reported a position in Zymeworks in Q2 2018 and has held it in 19 quarters since.
- Squarepoint's Zymeworks position peaked at $3.76M in Q3 2025.
- 203 funds tracked by Wall St. Rank held Zymeworks as of Q3 2026.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.